In this special edition of Ethics Talk, Dr Uché Blackstock joins us to discuss COVID-19 morbidity and mortality outcomes inequity by race and what needs to change now and postpandemic. Transcript available.
Alice Wong and Dr Joseph Stramondo join us on this special episode of Ethics Talk to discuss how perspectives from the disability community can help us think more powerfully about quality of life, resource allocation, and other ethical challenges arising in pandemics. Transcript available.
Annette Mendola, PhD and Richard L. Gibson, MD, MPH
Because research on the efficacy of approaches to addiction recovery is inconclusive, clinicians should recommend several, including 12-step approaches.
AMA J Ethics. 2016; 18(6):646-655. doi:
10.1001/journalofethics.2016.18.6.sect1-1606.
Professor john powell joins us for this special edition of Ethics Talk to discuss how a lens of “othering and belonging” can help us navigate our obligations to and relationships with each other, especially during this COVID-19 pandemic.
Jennifer D. Byrne, LCSW, CADC, Katie S. Clancy, MSW, and Isabell Ciszewski, LCSW
Social work perspectives on whether prescribers should authorize opioid refills emphasize the importance of multidisciplinary approaches to patient self-determination.
AMA J Ethics. 2020; 22(8):E658-663. doi:
10.1001/amajethics.2020.658.
Considering chronic opioid use when planning elective surgery would likely enhance team communication, decrease stigma, and facilitate care transitioning and long-term planning.
AMA J Ethics. 2020; 22(8):E664-667. doi:
10.1001/amajethics.2020.664.
Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful.
AMA J Ethics. 2020; 22(8):E723-728. doi:
10.1001/amajethics.2020.723.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022; 24(4):E319-325. doi:
10.1001/amajethics.2022.319.